Travis Sullivan to Adenocarcinoma
This is a "connection" page, showing publications Travis Sullivan has written about Adenocarcinoma.
Connection Strength
0.329
-
Burks EJ, Sullivan TB, Rieger-Christ KM. Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial. Cancer Biomark. 2025 Jan; 42(1):CBM230452.
Score: 0.175
-
Yambayev I, Sullivan TB, Rieger-Christ KM, Servais EL, Stock CT, Quadri SM, Sands JM, Suzuki K, Burks EJ. Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy. Lung Cancer. 2022 09; 171:82-89.
Score: 0.154